Debu Tripathy

The University of Texas MD Anderson Cancer Center — United States

Medicine · Health Sciences

68h-index25.3kcitations1.2kworks2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Breast Cancer Therapies(362), Breast Cancer Treatment Studies(252), Cancer Treatment and Pharmacology(236), HER2/EGFR in Cancer Research(235), Lung Cancer Research Studies(100)

Publications1.2k total

Retrospective review of metastatic hormone receptor-positive inflammatory breast cancer patients reveals poor responses to cyclin dependent kinase 4/6 inhibition
Breast Cancer Research·2025· 1 citedOpen Access
Supplemental Figures and Figure Legends from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
2025Open Access
Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
2025Open Access
Supplementary Materials and Methods from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
2025Open Access
Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancer
npj Breast Cancer·2025Open Access
Prolonged Tamoxifen treatment augments neutrophil extracellular trap formation in ER+ breast cancer patients 3464
The Journal of Immunology·2025Open Access
Real-world effectiveness of palbociclib plus hormone treatment and its impact on patient quality of life: a plain language summary of findings from POLARIS
Future Oncology·2025Open Access
Imaging- and Tumor Biomarker–Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer
JCO Precision Oncology·2025Open Access
Enhancing the interpretation of real-world quality of life in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer enrolled in the POLARIS study
The Oncologist·2025Open Access
Figure S2 from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
Figure S3 from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
Table S1 from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
Figure S1 from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
Data from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
Figure S4 from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
Supplementary Materials and Methods from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
Table S2 from Inhibition of <i>MCL-1</i> and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers
2025Open Access
Adjuvant capecitabine in patients with triple-negative breast cancer after neoadjuvant chemotherapy
ESMO Open·2025Open Access
BSBM-01 TARGETING CXCL1 - CXCR2 AXIS BLOCKS BRAIN METASTASIS IN INFLAMMATORY BREAST CANCER
Neuro-Oncology Advances·2025Open Access
Circulating Tumor DNA Genotyping of Intrinsic and Acquired Gene Alterations in Patients With Advanced Breast Cancer Receiving Palbociclib: Biomarker Results From POLARIS Study
JCO Precision Oncology·2025· 1 citedOpen Access
page 1 of 58Next →

Frequent Co-authors

Melody Cobleigh(8), Dennis J. Slamon(7), Charles L. Vogel(6), Hope S. Rugo(6), Louis Fehrenbacher(5), Steven Shak(5), Sara A. Hurvitz(5), Angela DeMichele(4), Lyndsay N. Harris(3), William Novotny(3), Michael Burchmore(3), Stanford J. Stewart(3), José Baselga(3), Sharon A. Baughman(3), T. Twaddell(3), Daniel F. Hayes(3), Suzanna M. Zick(3), Christina Yau(3), Denise M. Wolf(3), A. Jo Chien(3)